Nanda, Arjun S. http://orcid.org/0000-0001-5014-3104
Wu, Ke
Irkliyenko, Iryna
Woo, Brian
Ostrowski, Megan S. http://orcid.org/0000-0001-9845-9319
Clugston, Andrew S.
Sayles, Leanne C. http://orcid.org/0000-0003-3963-6412
Xu, Lingru
Satpathy, Ansuman T. http://orcid.org/0000-0002-5167-537X
Nguyen, Hao G.
Alejandro Sweet-Cordero, E. http://orcid.org/0000-0002-9787-9351
Goodarzi, Hani http://orcid.org/0000-0002-9648-8949
Kasinathan, Sivakanthan http://orcid.org/0000-0003-2218-6371
Ramani, Vijay http://orcid.org/0000-0003-3345-5960
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (DP2HG012442)
U.S. Department of Health & Human Services | National Institutes of Health (T32AR050942, R01CA243555, R01GM123977)
Article History
Received: 9 August 2022
Accepted: 8 April 2024
First Online: 9 May 2024
Competing interests
: V.R., S.K., A.S.N., H.G. and K.W. are inventors on a provisional patent related to this study. A.T.S. is a scientific founder of Immunai, founder of Cartography Biosciences, founder of Prox Biosciences, advisor to Zafrens, advisor to Pallando Therapeutics, advisor to Wing Venture Capital, and receives research funding from Merck Research Laboratories. The other authors declare no competing interests.